US 2003/0158158 A1 · Oct preparations

Abstract

An object of the present invention is to provide OCT formulations showing excellent stability. According to the present invention, OCT formulations comprising 1α,25-dihydroxy-22-oxavitamin D3 (OCT) and a pH modifier are provided.

Claims4

Dependent claims

An OCT formulation comprising 1α,25-dihydroxy-22-oxavitamin D3 (OCT) and a pH modifier.

Dependencies are inferred from the claim text.

Facts

Application

10/332,695Filed 13 Jan 2003

Priority

JP 2000-26014930 Aug 2000

Published

21 Aug 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 47/02
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…:…
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 31/593
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
A61P 3/02
Drugs for disorders of the metabolism: nutrients, e.g. vitamins, minerals

Oct preparations

Life of this patent

Abstract

Claims4

Oct preparations

Life of this patent

Abstract

Claims4